You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR LUSUTROMBOPAG

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LUSUTROMBOPAG

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01054443 ↗	A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)	Terminated	Shionogi	Phase 2	2010-03-18	The primary objective of this study was to assess the efficacy of 3 dose levels of lusutrombopag (0.5 mg, 0.75 mg, and 1.0 mg) and placebo on platelet count.
NCT01129024 ↗	An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)	Terminated	Shionogi	Phase 2	2010-04-29	The primary objective of this study was to assess the long-term safety of lusutrombopag in the treatment of adults with relapsed persistent or chronic ITP with or without prior splenectomy.
NCT02389621 ↗	Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures	Completed	Shionogi	Phase 3	2015-06-15	The primary purpose of this study is to compare the efficacy of lusutrombopag with placebo for the treatment of thrombocytopenia in patients with chronic liver disease who are undergoing elective invasive procedures.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LUSUTROMBOPAG

Condition Name

Chart
Table

Condition Name for LUSUTROMBOPAG
Intervention	Trials
Chronic Liver Disease	1
Immune Thrombocytopenia	1
Immune Thrombocytopenia (ITP)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LUSUTROMBOPAG
Intervention	Trials
Thrombocytopenia	3
Purpura, Thrombocytopenic, Idiopathic	2
Liver Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LUSUTROMBOPAG

Trials by Country

Map
Table

Trials by Country for LUSUTROMBOPAG
Location	Trials
United States	37
Canada	1
United Kingdom	1
Germany	1
Italy	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LUSUTROMBOPAG
Location	Trials
Louisiana	3
Florida	3
District of Columbia	3
California	3
Texas	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LUSUTROMBOPAG

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LUSUTROMBOPAG
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LUSUTROMBOPAG
Clinical Trial Phase	Trials
Terminated	2
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LUSUTROMBOPAG

Sponsor Name

Chart
Table

Sponsor Name for LUSUTROMBOPAG
Sponsor	Trials
Shionogi	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LUSUTROMBOPAG
Sponsor	Trials
Industry	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.